Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
- 31 March 2004
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 25 (3), 273-281
- https://doi.org/10.1016/s0197-4580(03)00086-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammationJournal of Neurochemistry, 2002
- Cerebrospinal fluid Ab40 and Ab42: natural course and clinical usefulnessFrontiers in Bioscience-Landmark, 2002
- Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disordersMechanisms of Ageing and Development, 2001
- Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Neurobiology of Aging, 1998
- Evaluation and Use of Diagnostic Tests in Alzheimer’s DiseaseNeurobiology of Aging, 1998
- Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot AssayPublished by Elsevier BV ,1996
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975